IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Frontiers in Clinical Drug Research - Anti Infectives

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.00

h-Index

2024-2025

 3

Rank

2024-2025

 28191

SJR

2024-2025

 0.112

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Frontiers in Clinical Drug Research - Anti Infectives
Abbreviation Front. Clin. Drug Res. - Anti Infect.
Publication Type Book series
Subject Area, Categories, Scope Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)
h-index 3
Overall Rank/Ranking 28191
SCImago Journal Rank (SJR) 0.112
Impact Score 0.00
Publisher Bentham Science Publishers
Country Netherlands
ISSN 24523208, 23523212
Best Quartile Q4
Coverage History 2019-2021




About Frontiers in Clinical Drug Research - Anti Infectives


Frontiers in Clinical Drug Research - Anti Infectives is a book series covering the technologies/fields/categories related to Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4). It is published by Bentham Science Publishers. The overall rank of Frontiers in Clinical Drug Research - Anti Infectives is 28191. According to SCImago Journal Rank (SJR), this book series is ranked 0.112. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 3. The best quartile for this book series is Q4.

The ISSN of Frontiers in Clinical Drug Research - Anti Infectives book series is 24523208, 23523212. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Frontiers in Clinical Drug Research - Anti Infectives is cited by a total of 3 articles during the last 3 years (Preceding 2024).


Frontiers in Clinical Drug Research - Anti Infectives Impact IF 2024-2025


The Impact IF 2024 of Frontiers in Clinical Drug Research - Anti Infectives is 0.00, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact IF Trend


Year wise Impact IF of Frontiers in Clinical Drug Research - Anti Infectives. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.00
2023 0.00
2022 0.15
2021 0.57
2020 0.43
2019 0.00

Frontiers in Clinical Drug Research - Anti Infectives h-index


  Table Setting

Frontiers in Clinical Drug Research - Anti Infectives has an h-index of 3. It means 3 articles of this book series have more than 3 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Frontiers in Clinical Drug Research - Anti Infectives ISSN


The ISSN of Frontiers in Clinical Drug Research - Anti Infectives is 24523208, 23523212. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Frontiers in Clinical Drug Research - Anti Infectives Rank and SCImago Journal Rank (SJR)


The overall rank of Frontiers in Clinical Drug Research - Anti Infectives is 28191. According to SCImago Journal Rank (SJR), this book series is ranked 0.112. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Frontiers in Clinical Drug Research - Anti Infectives by Year


Year SJR
2025/2026 Coming Soon
2024 0.112
2023 0.104
2022 0.149
2021 0.359
2020 0.205
2019

Ranking of Frontiers in Clinical Drug Research - Anti Infectives by Year


Year Ranking
2025/2026 Coming Soon
2024 28191
2023 27349
2022 21985
2021 13074
2020 19007
2019 30969

Frontiers in Clinical Drug Research - Anti Infectives Publisher


Table Setting

Frontiers in Clinical Drug Research - Anti Infectives is published by Bentham Science Publishers. It's publishing house is located in Netherlands. Coverage history of this book series is as following: 2019-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Frontiers in Clinical Drug Research - Anti Infectives is Front. Clin. Drug Res. - Anti Infect.. This abbreviation ('Front. Clin. Drug Res. - Anti Infect.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Frontiers in Clinical Drug Research - Anti Infectives


If your research field is/are related to Drug Discovery (Q4); Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4), then please visit the official website of this book series.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Frontiers in Clinical Drug Research - Anti Infectives?

Frontiers in Clinical Drug Research - Anti Infectives latest impact IF is 0.00. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this book series are 0.57 (2021) and 0.00 (2024), respectively, in the last 6 years. Moreover, its average IS is 0.19 in the previous 6 years.


What's the SCImago Journal Rank (SJR) of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives has an SJR (SCImago Journal Rank) of 0.112, according to the latest data. It is computed in the year 2025. In the past 6 years, this book series has recorded a range of SJR, with the highest being 0.359 in 2021 and the lowest being in 2019. Furthermore, the average SJR of the Frontiers in Clinical Drug Research - Anti Infectives over the previous 6-year period stands at 0.19.


What's the latest h-index of the Frontiers in Clinical Drug Research - Anti Infectives?

The latest h-index of the Frontiers in Clinical Drug Research - Anti Infectives is 3.


Who's the publisher of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives is published by the Bentham Science Publishers, with its country of publication being the Netherlands.


What's the current ranking of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives is currently ranked 28191 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 6 years, this book series has experienced varying rankings, reaching its highest position of 13074 in 2021 and its lowest position of 30969 in 2019.


What's the abbreviation or short name for the Frontiers in Clinical Drug Research - Anti Infectives?

The standard ISO4 abbreviation for the Frontiers in Clinical Drug Research - Anti Infectives is Front. Clin. Drug Res. - Anti Infect..


Is the "Frontiers in Clinical Drug Research - Anti Infectives" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Frontiers in Clinical Drug Research - Anti Infectives is classified as a book series that the Bentham Science Publishers publishes.


What's the scope or major areas of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives encompasses the following areas:

  • Drug Discovery
  • Infectious Diseases
  • Pharmacology
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this book series.


What's the ISSN of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives is assigned the following International Standard Serial Numbers (ISSN): 24523208, 23523212.


What's the best quartile of the Frontiers in Clinical Drug Research - Anti Infectives?

The best quartile for the Frontiers in Clinical Drug Research - Anti Infectives is Q4 (2024).


What's the coverage history of the Frontiers in Clinical Drug Research - Anti Infectives?

The Frontiers in Clinical Drug Research - Anti Infectives coverage history can be summarized as follows: 2019-2021.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
European Union Politics journal 1953 SAGE Publications Ltd 79 3.71
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
Journal of International Financial Management and Accounting journal 1434 Wiley-Blackwell Publishing Ltd 50 10.53
Sex Education journal 6348 Routledge 51 2.49
Archives of the Balkan Medical Union journal 26504 Balkan Medical Union 13 0.20
Proceedings of the Royal Society of Queensland journal 28017 Royal Society of Queensland 12 0.17
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
Expert Review of Clinical Pharmacology journal 4295 Taylor and Francis Ltd. 67 3.02
International Journal of Press/Politics journal 833 SAGE Publications Inc. 87 8.82

Check complete list




Year wise Impact Score (IS) of Frontiers in Clinical Drug Research - Anti Infectives

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.00
2023 0.00
2022 0.15
2021 0.57
2020 0.43
2019 0.00



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Protein and Cell
Oxford University Press | United Kingdom

Molecular Therapy
Cell Press | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Ltd | United Kingdom

MedComm
John Wiley and Sons Inc | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Archives of Pharmacal Research
Pharmaceutical Society of Korea | South Korea

See All

Top Journals/Conferences in Infectious Diseases

Nature Reviews Microbiology
Nature Research | United Kingdom

Immunity
Cell Press | United States

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Infectious Diseases, The
Elsevier Ltd | United Kingdom

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Lancet Microbe, The
Elsevier Ltd | United Kingdom

Lancet HIV,The
Elsevier Ltd | United Kingdom

Gut Microbes
Landes Bioscience | United States

FEMS Microbiology Reviews
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All